EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
From FDA approvals to new studies, here are X updates on two-level disc replacement to know, as reported by Becker’s since May 29: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback